BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
23.18
+1.05 (4.74%)
At close: Jan 21, 2026, 4:00 PM EST
23.98
+0.80 (3.45%)
Pre-market: Jan 22, 2026, 8:38 AM EST
BrainsWay Market Cap
BrainsWay has a market cap or net worth of $451.3 million as of January 22, 2026. Its market cap has increased by 162.75% in one year.
Market Cap
451.30M
Enterprise Value
384.43M
1-Year Change
162.75%
Ranking
Category
Stock Price
$23.18
Market Cap Chart
Since September 3, 2013, BrainsWay's market cap has increased from $178.92M to $451.30M, an increase of 152.23%. That is a compound annual growth rate of 7.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 451.30M | 17.57% |
| Dec 31, 2025 | 383.87M | 112.82% |
| Dec 31, 2024 | 180.37M | 70.88% |
| Dec 31, 2023 | 105.55M | 216.46% |
| Dec 29, 2022 | 33.35M | -73.96% |
| Dec 30, 2021 | 128.06M | 62.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 289.32B |
| Novartis AG | 278.23B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 261.50B |